研究人员发现,将人工血管细胞添加到胎盘移植中可能会扭转小鼠的糖尿病。 Researchers find adding engineered blood vessel cells to islet transplants may reverse diabetes in mice.

Weill Cornell Medicine的研究人员发现,在小类移植中添加工程血管细胞可以提高胰岛素生产细胞存活率,并扭转小鼠的糖尿病。 Researchers at Weill Cornell Medicine have found that adding engineered blood vessel cells to islet transplants can boost insulin-producing cell survival and reverse diabetes in mice. 这可能导致对1型糖尿病的更有效治疗,有可能消除对免疫抑制药物的需求。 This could lead to a more effective treatment for type 1 diabetes, potentially eliminating the need for immunosuppressive drugs. 这项研究显示了希望,但在扩大和确保人类病人的长期成功方面面临着挑战。 The study shows promise but faces challenges in scaling up and ensuring long-term success in human patients.